Ingrid Teigland Akay, MD MBA

Ingrid Teigland Akay, MD, MBA, is a prominent figure in the healthcare and biotechnology sectors. She currently serves as a board member at Alex Therapeutics, a company specializing in digital therapeutics, where she plays a crucial role in guiding its strategic direction and growth initiatives.12

Professional Background

Dr. Akay is the founder and managing partner at Hadean Ventures, a venture capital firm that invests in early-stage life sciences companies. Her expertise spans various areas including research and development, commercialization, and clinical practice. She has experience in general medicine, surgery, and psychiatry, which equips her with a comprehensive understanding of both healthcare delivery and business operations.12

Education

Dr. Akay holds a medical degree from Medizinische Hochschule Hannover and an MBA in Finance from London Business School. This combination of medical training and business acumen enables her to navigate the complexities of the healthcare industry effectively.14

Contributions

In her role at Alex Therapeutics, Dr. Akay has been involved in significant financing efforts aimed at expanding the company's capabilities in developing prescription digital therapies. Her leadership is instrumental in fostering partnerships with pharmaceutical companies to enhance patient outcomes through innovative therapeutic solutions.23

Dr. Akay's extensive background and strategic insights make her a valuable asset to both Alex Therapeutics and the broader life sciences community.